Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The purpose of this study is to assess the safety and efficacy of brodalumab taken every two weeks at two different doses.
Epistemonikos ID: 870c85fa59af501d0bd07ab2df0826d32bdc1efa
First added on: May 22, 2017